Last Updated: October 31, 2020    

Research Featured

Resources from 2020 Conference on Retroviruses and Opportunistic Infections

CROI 2020

HIV postexposure prophylaxis-in-pocket: long-term follow-up of individuals with low-frequency, high-risk HIV exposures

AIDS 2020, 34:433–437

Prevention of HIV for persons with low-frequency, high-risk exposures: PrEP (preexposure prophylaxis), PEP (postexposure prophylaxis), or ‘PIP’ (postexposure prophylaxis in-pocket)

AIDS 2020, 34:481–482

News Updates

Address Medical Mistrust to Recruit Minorities to COVID-19 Trials

Medscape | October 29, 2020

HIV up close: Unprecedented view of virus reveals essential steps for causing AIDS 

Medical Xpress | October 8, 2020

Study Solves an HIV Mystery | October 7, 2020

NIH Awards Will Advance HIV Implementation Research in U.S. Communities | September 29, 2020

Multiple COVID-19 Clusters on a University Campus — North Carolina, August 2020

CDC | September 29, 2020

Recent Increase in COVID-19 Cases Reported Among Adults Aged 18–22 Years — United States, May 31–September 5, 2020

CDC | September 29, 2020

ViiV Healthcare announces start of implementation science study to identify and evaluate approaches to integrating its investigational, every-two-month, injectable HIV treatment in European healthcare practices

ViiV Healthcare | September 28, 2020

$111M Grant to Focus on HIV-Related Cancers [VIDEOS] 

POZ | September 24, 2020

New Long-Acting Injectable HIV Drug Shows Promise in Monkey Study

POZ | September 2, 2020

CytoDyn Will Attempt to Duplicate Berlin and London Patients' HIV Cure by Using Leronlimab  During Bone Marrow Transplant for 5 HIV Patients Who also have Cancer

GlobeNewswire | August 17, 2020

FDA Clears Maryland Company's Potential HIV Cure For Human Trials 

CBS Baltimore | August 12, 2020

OPINION: Why SisterLove pushes for more women in HIV clinical trials 

Atlanta Journal Constitution | August 11, 2020

Moderna, Pfizer move to include HIV-positive volunteers in Phase 3 trials of COVID-19 vaccines 

Firstpost | August 10, 2020

Viral Load Dynamics in Sputum and Nasopharyngeal Swab in Patients with COVID-19

Journal of Dental Research | August 3, 2020

Top 5 HIV cure and vaccine stories from AIDS 2020 

aidsmap | July 30, 2020

NIAID and Partners to Develop Antibody-Based Products for HIV Prevention and Treatment blog | July 21, 2020

Examining adherence barriers among women with HIV to tailor outreach for long-acting injectable antiretroviral therapy

BMC Blogs Network | July 25, 2020

Summary of Important AIDS 2020 Virtual Abstracts for ACTG

ACTG | July 7, 2020

Dewpoint Therapeutics Collaborates with Merck to Evaluate Novel Approach for the Treatment of HIV

July 13th, 2020 | Dewpoint

HPTN 083: Efficacy of Pre-exposure Prophylaxis (PrEP) containing Long-acting injectable cabotegravir (CAB-LA) is maintained across regions and key populations

NATAP | July 10, 2020

Final HIV Research Highlights from AIDS 2020 blog | July 10, 2020

New $3.7M grant to support research exploring mysterious link between cancer, HIV/AIDS 

Newswise | July 8, 2020

HIV Research Highlights from AIDS 2020 blog | July 8, 2020

AIDS 2020: Researchers describe a possible case of HIV remission and a new method to prevent infection

CNN | July 7, 2020

Duke researchers help discover gene mutation that spreads the coronavirus faster 

WPVI-TV | July 3, 2020

UCLA receives nearly $14M from NIH for gene therapy to fight HIV/AIDS 

FOX 11 Los Angeles | June 15, 2020

How Close Are We to a Cure for HIV? | June 11, 2020

WIRED Examines Underrepresentation Of Women In HIV Prevention Drug Trials Testing PrEP 

Kaiser Family Foundation | June 11, 2020

Cure, Vaccine Trials Show HIV Rebounds Quickly in Semen| June 7, 2020

Update on HIV PrEP Research Among Cisgender Women

NATAP | May 28, 2020

New HIV vaccine strategy strengthens, lengthens immunity in primates 

Science Daily | May 11, 2020

Research Moves Toward Once-Yearly HIV Treatment

WebMD | April 30, 2020

Uptake and willingness to use PrEP among Chinese gay, bisexual and other men who have sex with men with experience of sexualized drug use in the past year

BMC Infect Dis. 2020 Apr 22;20(1):299. doi: 10.1186/s12879-020-05024-4

Oral sex: A new, and possibly the most dangerous, route of toxoplasmosis transmission

Med Hypotheses. 2020 Apr 9;141:109725. doi: 10.1016/j.mehy.2020.109725

ViiV Healthcare and UNC-Chapel Hill announce five-year renewal of innovative HIV cure partnership

ViiV | March 9, 2020

ViiV Healthcare initiates study with the University of South Carolina to evaluate the benefits of ride-sharing services on improving access to care for people living with HIV

ViiV | March 2, 2020

Pomalidomide Clears Anal Cancer Precursor in High Proportion With or Without HIV

CROI 2020, March 8-11, 2020, Boston

Intact Proviral HIV DNA Drops During Long-Term Suppressive ART
CROI 2020, March 8-11, 2020, Boston

Weekly Islatravir Protects Monkeys Against IV Challenge With SIV

CROI 2020, March 8-11, 2020, Boston

Greater Population-Level Viral Control Tied to Lower HIV Incidence in 4 Large Trials

CROI 2020, March 8-11, 2020, Boston

Drug-delivery technology leads to sustained HIV antibody production in NIH study

CROI 2020, March 8-11, 2020, Boston

NIH Study Finds Lower Concentration of PrEP Drug in Pregnant Young Women | March 9, 2020

Cure for HIV/AIDS: Scientists Discovers Genes to End HIV Infection from Source 

Hiptoro | February 21, 2020

New strategies drive HIV from cellular hiding places

NIH | February 4, 2020

Regional brain volumetric changes despite 2 years of treatment initiated during acute HIV infection

AIDS. 2020 Mar 1;34(3):415-426. doi: 10.1097/QAD.0000000000002436.

Study Finds Discrepancies From Guidelines in Prescribing Practices for Pregnant Women Living With HIV Managed Markets Network | February 2, 2020

HIV/AIDS cure: Human trials to start soon as scientists successfully cure HIV in monkeys and mice 

EconoTimes | January 31, 2020

Cure for HIV/AIDS: Scientists Cure HIV in Monkeys, Human Trials to Start Soon 

Hiptoro | January 2020

NIAID Launches First Clinical Trial to Test Antibody-Drug Combination for Long-Acting HIV Treatment | January 22, 2020

HIV Dental Symposium registration information

NIH Strategic Plan for HIV and HIV-Related Research | January 16, 2020

IAVI Makes Available Unique Dataset and Samples from Pioneering HIV/AIDS Study in Africa to Researchers

Yahoo Finance | January 14, 2020

Saag named an editor of the Journal of the International AIDS Society 

UAB News | January 10, 2020

Antibody Combination Prevents HIV Transmission from Mother to Infant 

Genetic Engineering & Biotechnology News | January 9, 2020

Kidney Donor's HIV Strain Found in HIV-Positive Recipient 

MedPage Today | January 8, 2020

Cuba advances HIV/AIDS vaccine project 

CGTN | December 21, 2019

Estimation of new HIV diagnosis rates among high-risk, PrEP-eligible individuals using HIV surveillance data at the Metropolitan Statistical Area level in the United States

Journal of the International AIDS Society | December 20, 2019

How Close Are We to Curing HIV? | December 13, 2019

Unsung heroes: Pittsburgh men, decades-long study impact HIV/AIDS research 

TribLIVE | December 15, 2019

Vesicles released by bacteria may reduce the spread of HIV in human tissue

NIH | December 11, 2019

Gay, bisexual men increasingly agree: HIV “Undetectable Equals Untransmittable”

NIH | December 5, 2019

Preventive HIV vaccine Enters Phase 3 Global Study

IAS 2019: Conference on HIV Pathogenesis Treatment and Prevention Mexico City July 21-24 2019

The Future—And the End?—of AIDS 

Columbia University Irving Medical Center | November 27, 2019

ViiV Healthcare announces exclusive licensing agreement with the National Institutes of Health for investigational “bNAb” with potential for long-acting HIV treatment and prevention

ViiV | November 21, 2019

Colonic microbiota exhibits disparate associations with HIV infection and sexual practices

21st International Workshop n Co-morbidities and Adverse Drug Reactions in HIV

Only 1% HIV Diagnosis Rate More Than 6 Months After PEP in 975 People

17th European AIDS Conference, November 6-9, 2019, Basel

Maryland Medical Company Claims To Have Cure For HIV, AIDS 

CBS Pittsburgh | November 8, 2019

First New HIV Strain in 19 Years Identified 

Scientific American | November 6, 2019

Researchers adapt CAR-T immunotherapy to target the HIV latent reservoir 

Medical Xpress | October 24, 2019

NIH Launches New Collaboration to Develop Gene-Based Cures for Sickle Cell Disease and HIV on Global Scale | October 24, 2019

The Future of ARV-Based Prevention and More | October 23, 2019

NIH launches new collaboration to develop gene-based cures for sickle cell disease and HIV on global scale

NIH | October 23, 2019

Drug reverses signs of liver disease in people living with HIV

NIH | October 15, 2019

The Dose Response: Perceptions of People Living with HIV in the United States on Alternatives to Oral Daily Antiretroviral Therapy

AIDS Res Hum Retroviruses. 2019 Oct 14. doi: 10.1089/AID.2019.0175

Study demonstrates antibody responses within 6 weeks of initial vaccination 

EurekAlert | October 1, 2019

AIDS Treatment: Russian Researchers Create New Medications 

QS WOW News | September 29, 2019

UAB researchers land funding to combat HIV 

Birmingham Business Journal | September 27, 2019

UC San Diego Researchers Isolate Switch that Kills Inactive HIV 

UC San Diego Health | September 24, 2019

Papillomaviruses May Be Able To Be Spread By Blood

EurekAlert | September 11, 2019

CRISPR shown to be safe to target HIV (but unsuccessful so far) 

The Daily Briefing | September 13, 2019

An open-label phase 1 clinical trial of the anti-α4β7 monoclonal antibody vedolizumab in HIV-infected individuals

Science Translational Medicine | September 7, 2019

The disconnect between individual-level and population-level HIV prevention benefits of antiretroviral treatment 

The Lancet | September 2019

Long-acting or extended-release antiretroviral products for HIV treatment and prevention in infants, children, adolescents, and pregnant and breastfeeding women: knowledge gaps and research priorities 

The Lancet | September 2019

Comparison of Measures of Adherence to Human Immunodeficiency Virus Preexposure Prophylaxis Among Adolescent and Young Men Who Have Sex With Men in the United States.

Clin Infect Dis. 2018 Jan 6;66(2):213-219. doi: 10.1093/cid/cix755.

Cellular therapies are the next big step in fight against HIV/Aids 

Independent Online | August 31, 2019

Animal activists are on the wrong side of the fight against AIDS 

STAT | August 30, 2019

Arrowhead Collaborator Janssen Begins REEF-1 Phase 2b Combination Study in Patients with Chronic Hepatitis B Infection

BusinessWire | August 28, 2019

Repeated semen exposure promotes host resistance to infection in preclinical HIV model 

EurekAlert | August 21, 2019

New Molecule Identified That May Further Suppress Effectively Treated HIV

POZ | August 14, 2019

Cancer therapy returns to original target: HIV 

Science Magazine | August 9, 2019

HOPE trial: Dapivirine vaginal ring reduces HIV risk by estimated 39% 

Healio | August 6, 2019

Structure-guided drug design identifies a BRD4-selective small molecule that suppresses HIV

JCI | July 22, 2019

Johnson & Johnson Announces New Public-Private Partnership to Support First Phase 3 Efficacy Study of Janssen’s Investigational Prophylactic HIV Vaccine

IAS 2019: Conference on HIV Pathogenesis Treatment and Prevention, Mexico City, July 21-24 2019

PrEP use high but wanes after three months among young African women

NIH | July 23, 2019

Developing a novel HIV vaccine: DNA and recombinant proteins 

Science Daily | July 23, 2019

Duke Human Vaccine Institute receives $129 million grant for HIV/AIDS research 

Duke Chronicle | July 19, 2019

HIV Testing and Treatment with the Use of a Community Health Approach in Rural Africa

New England Journal of Medicine | July 18, 2019

Effect of Universal Testing and Treatment on HIV Incidence — HPTN 071 (PopART)

New England Journal of Medicine | July 18, 2019

Universal Testing, Expanded Treatment, and Incidence of HIV Infection in Botswana

New England Journal of Medicine | July 18, 2019

HIV-1 Epidemic Control — Insights from Test-and-Treat Trials, Slim Abdool Karim

New England Journal of Medicine | July 18, 2019

Acceptability and Preferences for Long-Acting Antiretroviral Formulations Among People Living with HIV infection

IAPAC Adherence June 17-19 Miami

Enlisting CRISPR in the Quest for an HIV Cure

NIH | July 16th, 2019

Johnson & Johnson to start testing on new type of HIV vaccine in US and Europe 

New York Daily News | July 13, 2019

Consortium Led by Scripps Research Gets $129 Million for HIV/AIDS Vaccine Clinical Trials 

Times of San Diego | July 10, 2019

HIV-1 self-testing to improve the efficiency of pre-exposure prophylaxis delivery: a randomized trial in Kenya

Trials. 2019 Jul 4;20(1):396. doi: 10.1186/s13063-019-3521-2.

HIV eliminated from the genomes of living animals

Nature Communications | June 2019

Genotype Testing at HIV Diagnosis Provides No Benefit 

Infectious Disease Advisor | June 24, 2019

Augmentation of HIV-specific T cell function by immediate treatment of hyperacute HIV-1 infection

Science Translational Medicine | June 15, 2019

AIDSinfo Updates Investigational HIV Drug Fact Sheets

AIDSinfo | June 14, 2019

Women and Clinical Trials

The New York Times | June 14, 2019

GSK partners with CRISPR pioneer Doudna to search for new drugs

STAT News | June 13, 2019

Durable Control of HIV Infection in the Absence of Antiretroviral Therapy - Opportunities and Obstacles

Viewpoint | June 6, 2019

Trump administration imposes new restrictions on fetal tissue research

Washington Post | June 5, 2019

Statement from the Department of Health and Human Services | June 5, 2019

Assessment of the Safety of Pembrolizumab in Patients With HIV and Advanced Cancer—A Phase 1 Study

JAMA Oncol. Published online June 2, 2019

HIV Vaccine Awareness Day 2019 — May 18, 2019

National Institutes of Health | May 17, 2019

Celgene Corporation Announces POMALYST® Granted Breakthrough Therapy Designation from ...

Yahoo Finance | May 13, 2019

NIH Trial Evaluates Long-acting HIV Medication Unable to Adhere to Strict Daily Regimens - LATITUDE study compares monthly injectable antiretroviral therapy to daily oral drugs

NIH | May 9, 2019

NIH awards will advance development of vaccines for sexually transmitted infections

NIH | May 5, 2019

Advanced stage at diagnosis and elevated mortality among US patients with cancer infected with HIV in the National Cancer Data Base

Cancer. 2019 May 3. doi: 10.1002/cncr.32158

Boston hospital receives largest philanthropic gift in history for HIV/AIDS vaccine research

WCVB Boston | April 25, 2019

Novel antibody may suppress HIV for up to four months

NIH | April 17, 2019

Scientists find another way HIV can hide from vaccines

Yale News | April 10, 2019

Orion Biotechnology to Present OB-002 in Vitro Potency Data at the 10th International AIDS Society HIV Science Meeting in Mexico City in July 2019

PR Newswire | March 28, 2019

Aaron Diamond AIDS Research Center to Join Columbia University

Columbia University | March 20, 2019

Curing HIV just got more complicated. Can CRISPR help?

Science Magazine | March 15, 2019

Potential effectiveness of prophylactic HPV immunization for men who have sex with men in the Netherlands: A multi-model approach

PLoS Med. 2019 Mar 4;16(3):e1002756. doi: 10.1371/journal.pmed.1002756. eCollection 2019 Mar.

This is Not A Cure for My H.I.V.

New York Times | March 9, 2019

One step closer to ultra-long-acting PREP?

AIDS: march 2019

New Target for HIV Immune Therapy and Cure to be Explored by Trans-Atlantic Industry-Academia Collaboration

NATAP | February 20th, 2019

Unintended HIV-1 Transmission to a Sex Partner in a Study of a Therapeutic Vaccine Candidate

HIV-1 vaccination by needle-free oral injection induces strong mucosal immunity and protects against SHIV challenge

Nat Commun. 2019 Feb 18;10(1):798. doi: 10.1038/s41467-019-08739-4

NIH Clinical Trial to Track Outcomes of Liver Transplantation from HIV-Positive Donors to HIV-Positive Recipients | February 15, 2019

Ending the HIV Epidemic: A Plan for the United States

NIH | February 7, 2019

Study of PrEP and vaginal ring for HIV prevention begins in girls and young women

NIH | February 7, 2019

HIV-AIDS drug could help treat Alzheimer's and other age-related diseases, Brown researchers say

The Providence Journal | February 6, 2019

Hodgkin's lymphoma and its association with EBV and HIV infection

Crit Rev Clin Lab Sci. 2018 Mar;55(2):102-114. doi: 10.1080/10408363.2017.1422692. Epub 2018 Jan 9

Safety and Efficacy of Immune Checkpoint Inhibitor Therapy in Patients With HIV Infection and Advanced-Stage Cancer

A Systematic Review

Oral cannabinoids in people living with HIV on effective antiretroviral therapy: CTN PT028-study protocol for a pilot randomised trial to assess safety, tolerability and effect on immune activation

BMJ Open. 2019 Jan 17;9(1):e024793. doi: 10.1136/bmjopen-2018-024793.

Heterosexual oral and anal sex in Kinshasa (D.R.Congo): Data from OKAPI prospective cohort

PLoS One. 2019 Jan 16;14(1):e0210398. doi: 10.1371/journal.pone.0210398. eCollection 2019

Incidence and Correlates of STIs among Black Men who have Sex with Men Participating in the HPTN 073 PrEP Study.

Clin Infect Dis. 2019 Jan 7. doi: 10.1093/cid/ciy1141.

Scientists achieve the first proof of concept for an HIV broadly-neutralising antibody vaccine in ...

aidsmap | January 2, 2019

Potential of HIV-Protective Drugs Administered Via Rectal Douches

Infectious Disease Advisor | December 26, 2018

AIDS -- an approach for targeting HIV reservoirs

Eurek Alert | December 20, 2018

AIDS: An approach for targeting HIV reservoirs

Science Daily | December 20, 2018

Study Determines Why Patients With HIV Have Higher Rates of Cancer Managed Markets Network | December 14, 2018

NIH to fund HIV care and prevention research in the South

Healio | December 14, 2018

Removable PrEP implant produces high drug levels in rabbits; further studies planned

aidsmap | November 15, 2018

Johns Hopkins researchers examine testosterone use to increase BMD in HIV-infected men

EurekAlert | December 12, 2018

A protein complex from human milk enhances the activity of antibiotics and drugs against Mycobacterium tuberculosis

Antimicrob Agents Chemother. 2018 Nov 12. pii: AAC.01846-18. doi: 10.1128/AAC.01846-18

With HIV/AIDS Research Threatened, NIH Looks For Stem-Cell Alternatives

Rolling Stone | December 11, 2018

Uganda starts tests for long acting injectable ARVs

New Vision | November 9, 2018